{
  "id": "cluster_9_doc2",
  "content": "Patient HX99802 (Halim Najjar, dob 06/15/1978) was approved for golimumab therapy after initial denials under policy TT-449K. The appeals process involved documentation of failed methotrexate treatment and bilateral sacroiliitis confirmed by MRI. Coordination between Sunset Hills pharmacy and Horizon Specialty Infusion Center required three authorization resubmissions.",
  "metadata": {
    "format": "medical_record"
  }
}